Article
Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
1 Jul 2017
Abstract excerpt
Prostate cancer is a complex disease that can be relatively harmless or extremely aggressive. Although androgen-deprivation therapy is a commonly used treatment for men with prostate cancer, the adverse effects can be detrimental to patient health and quality of life. Therefore, identifying new target genes for tumor growth will enable the development of novel therapeutic intervention. TPX2 plays a critical role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
